Prominent IP Updates on Jan 15, 2015

AstraZeneca loses German court appeal over Seroquel XR drug patent

AstraZeneca Plc on Tuesday lost an appeal in Germany’s Federal Court against generic drugmakers selling cheap copies of its anti-psychotic drug Seroquel XR.

NBCUniversal, Personal Audio Settle Podcast Patent Case

NBCUNIVERSAL MEDIA LLC has settled the patent infringement suit brought against it by PERSONAL AUDIO LLC, the firm claiming a patent for the process of distributing podcasts. The case was one of several brought against media companies by the patent holder, including the widely publicized case against ADAM CAROLLA’s podcast network, which was settled after CAROLLA aggressively fought back.

Orthocell receives Chinese patent for soft tissue repair technology

Orthocell has received a Chinese patent covering the manufacture of its Celgro collagen-based scaffold for the surgical repair of damaged soft tissue such as tendons, cartilage and eardrums.

India Rejects Gilead Patent Bid for Sovaldi Hepatitis C Treatment

India’s patent office has rejected an application from U.S.-based Gilead Sciences Inc for its hepatitis C drug Sovaldi, paving the way for local drugmakers to launch cheaper generic versions of the $1,000-a-pill medicine.

Aradigm Granted Key Composition of Matter Patents for Pulmaquin in Europe and Australia

Aradigm Corporation today announced that the European Patent Office has issued an important new composition of matter patent entitled “Dual Action, Inhaled Formulations Providing Both an Immediate and Sustained Release Profile,” (E.U. Patent No. 2,079,443) to Aradigm for formulations of liposomal and free ciprofloxacin.

3SBio Signs Exclusive Patent License Agreement for DIG-KT, a Bi-Specific mAb targeting VEGFR2 and Tie-2 with PharmAbcine

3SBio Inc. a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive licensing deal with PharmAbcine Inc. for the development, manufacturing and marketing of DIG-KT, a bi-specific monoclonal antibody (“mAb”) targeting both VEGFR2/KDR and Tie-2 pathways for cancer.

Apple “iBooks” Icon is now a Registered Trademark

Apple’s iBooks was first announced alongside the iPad at a press conference in January 2010. Today the US Patent & Trademark Office published Apple’s latest registered trademark for their iBooks icon that was revised for iOS 7. Apple originally filed for their trademark in the US on October 17, 2013.

Apple Granted Patent for Display-Based Speakers for iDevices

Apple’s newly granted patent covers their invention relating to electronic devices, and more particularly, to display-based speaker structures for electronic devices.

Acacia Subsidiary Enters into Settlement and Patent License Agreement with TomTom Inc

Acacia Research Corporation announced today that its American Vehicular Sciences LLC subsidiary has entered into a settlement and patent license agreement with TomTom Inc

Marathon Subsidiary TLI Communications LLC Enters Into License Agreement With Photobucket.com

Marathon Patent Group, Inc. a patent licensing company, announced today that on January 13, 2015, the company’s subsidiary TLI Communications LLC entered into a settlement and license agreement with Photobucket.com.

Oxford biotherapeutics Grants an Exclusive License to Boehringer Ingelheim

Oxford BioTherapeutics announces today that Boehringer Ingelheim has exercised an option to receive exclusive rights to an oncology target from an ongoing discovery collaboration.

National Research Council of Canada and KalGene Pharmaceuticals announce license agreement

National Research Council of Canada (NRC) has granted KalGene Pharmaceuticals an exclusive worldwide license for a therapeutic molecule against Alzheimer’s disease. With over 500,000 patients in Canada alone, the current cost of dementia care is over $15 billion dollars a year; as the baby boomer generation ages, costs are expected to rise to over $150 billion annually by 2038.

Mdxhealth Licenses Epigenetic Technology to Oncgnostics GmbH

MDxHealth SA a leading molecular diagnostics company in the field of personalized cancer treatment, today announced that it has granted a limited worldwide license for its patented methylation specific PCR (MSP) technology to Oncgnostics GmbH in Jena, Germany.

Intrexon announces exclusive licensing agreement with MD Anderson

Intrexon Corporation a leader in synthetic biology and its oncology partner, ZIOPHARM Oncology today announced a broad exclusive licensing agreement with The University of Texas MD Anderson Cancer Center, including an exclusive sublicensing agreement through MD Anderson for intellectual property developed at the University of Minnesota for the development of non-viral adoptive cellular cancer immunotherapies.

Biotech company with Mayo Clinic roots signs licensing deal

AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into a licensing agreement with Omnis Pharmaceuticals (Omnis), a privately-held biotechnology company focused on the development of oncolytic viruses. This agreement will allow MedImmune to combine key agents from its investigational immunotherapy portfolio with Omnis’ lead investigational oncolytic virus programme, a genetically engineered strain of vesicular stomatitis virus (VSV).

Apple patent points to iCloud-based Touch ID syncing, fingerprint-protected Apple Pay terminals

The U.S. Patent and Trademark Office on Thursday published an Apple patent application for an iCloud-based fingerprint storage and cross-device syncing solution, a system that could do away with manual Touch ID setup and power next-generation Apple Pay-enabled POS terminals.

Google’s new patent turns on private browsing automatically

Google has just been granted a patent for a way to automatically enable incognito mode on desktop and mobile browsers.

Samsung talks to BlackBerry about $7.5 bn buyout

Samsung Electronics recently offered to buy BlackBerry for as much as $7.5 billion, seeking its valuable patents as it battles Apple in the corporate market, according to a person familiar with the matter and documents seen by Reuters.

Johnny Gaudreau seeks trademark

Calgary Flames rookie Johnny Gaudreau, who has 13 goals and 19 assists this season, is seeking to patent and trademark “Johnny Hockey” in both the United States and Canada, TSN reported.

Inventor forced by Mindef to close company over patent rights

Facing a long-drawn and uphill lawsuit with the Ministry of Defence over a patent issue, Dr Ting Choon Meng, an innovator and medical professional, decided to withdraw his case due to mounting legal costs and a battle for which he saw no end in sight.